Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.64% | 148.52 | 0.0% | $1566.70m | |
| OCGN | Ocugen, Inc. | -3.69% | 9.65 | 0.0% | $1123.31m | |
| NVAX | Novavax, Inc. | -13.64% | 207.52 | 92.9% | $895.73m | |
| AMGN | Amgen, Inc. | 0.22% | 227.53 | 1.3% | $553.08m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.43% | 213.38 | 1.9% | $524.90m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.20% | 457.50 | 2.7% | $521.71m | |
| ILMN | Illumina, Inc. | -0.22% | 445.53 | 3.5% | $519.08m | |
| GILD | Gilead Sciences, Inc. | 1.73% | 63.54 | 1.0% | $487.81m | |
| BNGO | Bionano Genomics, Inc. | -1.37% | 9.71 | 0.0% | $358.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.51% | 151.19 | 2.0% | $356.41m | |
| BIIB | Biogen, Inc. | -0.31% | 272.40 | 1.7% | $332.20m | |
| CRSP | CRISPR Therapeutics AG | 0.12% | 130.41 | 0.6% | $309.94m | |
| EXAS | EXACT Sciences Corp. | -1.57% | 138.02 | 18.4% | $258.28m | |
| SGEN | Seagen Inc. | 0.96% | 154.01 | 5.8% | $212.51m | |
| VXRT | Vaxart, Inc. | -3.44% | 7.29 | 0.0% | $202.05m |
Company Profile
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.